SCHEMBL13290983

SCHEMBL13290983

Cc1nc(C(C)(C)C)c2c(C)c(C)c(C)c(C)c2c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13882103 0.81
SCHEMBL13933012 0.79
SCHEMBL861963 0.77
SCHEMBL77353 0.71 IDO1 (0.33)
SCHEMBL16671993 0.69
SCHEMBL16671994 0.69 KDM4E (0.32)
SCHEMBL16671991 0.69 KDM4E (0.32)
SCHEMBL12364140 0.68
SCHEMBL14572129 0.68
SCHEMBL8923194 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741281-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2010-06-22 US disclosed
US-20090105308-A1 Benzoheterocylethylcarboxamide derivatives BAYER CROPSCIENCE AG (DE) 2009-04-23 US disclosed
US-20070099825-A1 ethyl 2-(biphenyl-4-yl)-6-(tert-butoxycarbonylamino)-2-methoxy-8-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[n]pyrrolo[2,1-c][1,4,8]triazacyclopentadecine-14a-carboxylate; viricide; synergistic with other active ingredients BRISTOL-MYERS SQUIBB COMPANY 2007-05-03 US disclosed